Form 15-12G - Securities registration termination [Section 12(g)]
26 November 2024 - 1:05AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________
FORM 15
________________________
CERTIFICATION AND NOTICE OF TERMINATION
OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-38721
________________________
Axonics, Inc.
(Exact name
of registrant as specified in its charter)
________________________
26 Technology Drive
Irvine, California 92618
Tel: (949) 396-6322
(Address, including
zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common stock, par value $0.0001 per share
(Title of each class
of securities covered by this Form)
None
(Titles of all other
classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
________________________
Please place an X in the box(es) to designate
the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) |
☒ |
| Rule 12g-4(a)(2) |
☐ |
| Rule 12h-3(b)(1)(i) |
☒ |
| Rule 12h-3(b)(1)(ii) |
☐ |
| Rule 15d-6 |
☐ |
| Rule 15d-22(b) |
☐ |
Approximate number of holders of record as
of the certification or notice date: 1*
* Pursuant to an Agreement
and Plan of Merger, dated as of January 8, 2024, by and among Boston Scientific Corporation, a Delaware corporation (“Parent”),
Sadie Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and Axonics,
Inc., a Delaware corporation (the “Company”), Merger Sub merged with and into the Company, with the Company continuing
as the surviving corporation and as a wholly owned subsidiary of Parent.
Pursuant to the requirements of the Securities
Exchange Act of 1934, Axonics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized
person.
Date: November 25, 2024
| |
Axonics, Inc.
|
| |
| By: |
/s/ Susan Thompson |
| Name: |
Susan Thompson |
| Title: |
Vice President and Assistant Secretary |
Axonics (NASDAQ:AXNX)
Historical Stock Chart
From Dec 2024 to Jan 2025
Axonics (NASDAQ:AXNX)
Historical Stock Chart
From Jan 2024 to Jan 2025
